Veritas Intercontinental — Series B · €5M

Veritas Intercontinental is a spin-off of Veritas Genetics offering whole-genome sequencing (myGenome); Charme Capital Partners and Amadeus Capital Partners co-led the round. It pays for the company's own labs and R&D and takes total capital raised past €20M. Some sources call this round a Series A.

LeadCharme Capital Partners, Amadeus Capital Partners RoundSeries B Announced15 Oct 2020 CityMadrid SectorHealthtech & Bio · Genomics / Preventive medicine Source